Medivir’s CFO will leave his position - successor recruitment underway
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that Ola Burmark, Chief Financial Officer at Medivir will be leaving his position. He will continue to fulfill his duties until end of August. A recruitment process has begun to find his replacement. “Medivir has transformed into an oncology-focused research and development company with a broad pipeline of attractive projects. Ola has been an instrumental part of the executive leadership team in creating the new company and I want to thank him for his contributions and wish him good luck in his future career,” says